Dr. Vonderheide is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Boulevard
12-114 South
Philadelphia, PA 19104Phone+1 215-662-3929Fax+1 215-573-2652
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1998
Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
Harvard Medical SchoolClass of 1993
Certifications & Licensure
PA State Medical License 2001 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2007
Clinical Trials
- Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma Start of enrollment: 2010 Feb 01
- Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma Start of enrollment: 2012 Apr 01
- Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors Start of enrollment: 2005 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity.Nune Markosyan, Il-Kyu Kim, Charu Arora, Liz Quinones-Ware, Nikhil Joshi
JCI Insight. 2024-11-08 - Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.Urszula N Wasko, Jingjing Jiang, Tanner C Dalton, Alvaro Curiel-Garcia, A Cole Edwards
Nature. 2024-11-01 - 1 citationsNatural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors.Adham S Bear, Rebecca B Nadler, Mark H O'Hara, Kelsey L Stanton, Chong Xu
The Journal of Clinical Investigation. 2024-09-17
Journal Articles
- Unique Pattern of Neutrophil Migration and Function During Tumor ProgressionNeil Hockstein, Charles Mulligan, Robert H Vonderheide, Gregory Masters, Nature
- Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in CancerAndrew J Rech, Robert H Vonderheide, Jonathan J Kotzin, Clinical Cancer Research
Press Mentions
White House Names Abramson Cancer Center Neuro-Oncologist a Cancer Moonshot ScholarOctober 29th, 2024- Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO AwardsMay 23rd, 2023
- AACR Annual Meeting 2023: Closing Plenary Highlights Research Breakthroughs and Next StepsMay 22nd, 2023
- Join now to see all
Grant Support
- Combined CD40 Activation And CTLA4 Blockade In MelanomaNational Cancer Institute2011–2012
- Immunoregulation And Immunotherapy Of Breast CancerNational Cancer Institute2005–2011
- Telomerase As A Widely Expressed Tumor AntigenNational Cancer Institute2001–2004
- Telomerase As A Widely Expressed Tumor AntigenNational Cancer Institute2000–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
